Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid

NCT01772719 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Principal Investigator left institution-study not continued

Conditions

Multiple Myeloma

Interventions

DRUG: Simvastatin and zoledronic acid

Sponsor

University of Louisville

Collaborators

[object Object]